Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting

Ann Hematol. 2021 Apr;100(4):1089-1091. doi: 10.1007/s00277-020-04049-8. Epub 2020 May 6.

Authors

Kamal Kant Sahu¹, Kedar Mahagaokar², Bhavin Patel², Daniel Winokur², Sakiko Suzuki², Jennifer S Daly³, Muthalagu Ramanathan², Jan Cerny²

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, Saint Vincent Hospital, 123 Summer Street, Worcester, Massachusetts, 01608, United States. drkksahu85@gmail.com.
² Division of Hematology and Oncology, Department of Medicine, UMass Memorial Health Care, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts, 01655, United States.
³ Division of Infectious disease, UMass Memorial Health Care, University of Massachusetts Medical School,, 55 Lake Avenue North, Worcester, Massachusetts, 01655, United States.

PMID: 32372147
DOI: 10.1007/s00277-020-04049-8

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Abdomen / diagnostic imaging
Abdomen / parasitology
Abdomen / pathology
Aged
Animals
Antiparasitic Agents / therapeutic use
Blood Cell Count
Bronchoscopy
Daptomycin / therapeutic use
Enterococcus faecium / isolation & purification
Humans
Immunocompromised Host*
Immunotherapy
Ivermectin / therapeutic use
Lymphoma, Mantle-Cell / diagnostic imaging
Lymphoma, Mantle-Cell / microbiology
Lymphoma, Mantle-Cell / parasitology*
Lymphoma, Mantle-Cell / physiopathology
Male
Stem Cell Transplantation / adverse effects*
Strongyloides stercoralis / immunology
Strongyloides stercoralis / isolation & purification*
Strongyloidiasis / diagnosis*
Thiabendazole / therapeutic use
Tomography Scanners, X-Ray Computed

Substances

Antiparasitic Agents
Ivermectin
Thiabendazole
Daptomycin